The drug maker vaulted ahead of luxury goods maker LVMH to claim the title of Europe's most valuable company.

The American depositary receipts (ADRs) of Novo Nordisk (NVO), the market leader in weight-loss drugs, rose sharply in early trading Wednesday, hitting an all-time high, after the Danish company sa...

Novo Nordisk (NVO) reports better-than-expected fourth-quarter results, beating both earnings and revenues, driven by strong sales of Diabetes and Obesity care products.

Novo Nordisk president and CEO Lars Fruergaard Jørgensen joins 'Squawk Box' to discuss the company's quarterly earnings results, which reported better-than-expected 2023 earnings, surging demand fo...

TX, POWL and NVO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 31, 2024.

Novo Nordisk on Wednesday said its fourth-quarter profit surged by nearly two-thirds, driven by the popularity of its weight-loss drugs that have made it Europe's largest company.

Danish pharma giant Novo Nordisk on Wednesday reported better-than-expected earnings for 2023, propelled by a tsunami of demand for its blockbuster weight loss and diabetes drugs as new treatments ...

Novo Nordisk will more than double the amount of lower doses of its obesity drug Wegovy in the United States compared with recent months, CEO Lars Fruergaard Jorgensen said on Wednesday as the Dani...

Novo Nordisk, Europe's largest company by market capitalization, on Wednesday reported better-than-expected 2023 earnings.

Novo Nordisk on Wednesday posted fourth-quarter operating profit above expectations as it forecast another year of double-digit record sales growth due to its wildly popular Wegovy weight-loss drug.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm empl...

Novo Nordisk has been a great investment due to its drugs for diabetes and obesity. Madrigal Pharmaceuticals has big plans for treating a serious liver disease known as NASH.

Novo Nordisk (NVO) reachead $105.49 at the closing of the latest trading day, reflecting a -1.37% change compared to its last close.

Peloton is partnering with TikTok in a move that will make its content easier to find. Social media can play a big role in raising awareness around a product, as it did with Ozempic.

Drug stocks GSK, Sanofi, Merck KGaA, and Novartis look set for a good year on strong cash flows and attractive valuations, says UBS.